On Thursday, ADMA Biologics announced the commercial relaunch and first sales of its immune...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 22, 2019 at 5:02 PM.

  1. #1 cafead, Aug 22, 2019 at 5:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via On Thursday, ADMA Biologics announced the commercial relaunch and first sales of its immune globulin Bivigam, which is approved to treat patients suffering from any one of a family of inherited immune deficiencies that increase infection risks.

    article source
     
    Quote

Reply to Thread